You are here

Article info

Article menu

Download PDFPDF

Poster Presentations
12. Young researchers session
P12.02 Adaptor P329G-directed CAR T cells for modular targeting of AML

Authors

  • S Stock Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany German Cancer Consortium (DKTK), Partner Site Munich, Munich, German PubMed articlesGoogle scholar articles
  • T Strzalkowski Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • A Gottschlich Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • L Rohrbacher Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany PubMed articlesGoogle scholar articles
  • L Fertig Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • VD Menkhoff Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany PubMed articlesGoogle scholar articles
  • M Surowka Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland PubMed articlesGoogle scholar articles
  • P Bruenker Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland PubMed articlesGoogle scholar articles
  • D Darowski Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland PubMed articlesGoogle scholar articles
  • S Endres Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany German Cancer Consortium (DKTK), Partner Site Munich, Munich, German Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany PubMed articlesGoogle scholar articles
  • M von Bergwelt-Baildon Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany German Cancer Consortium (DKTK), Partner Site Munich, Munich, German PubMed articlesGoogle scholar articles
  • M Subklewe Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany German Cancer Consortium (DKTK), Partner Site Munich, Munich, German Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany PubMed articlesGoogle scholar articles
  • C Klein Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland PubMed articlesGoogle scholar articles
  • S Kobold Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany German Cancer Consortium (DKTK), Partner Site Munich, Munich, German Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany PubMed articlesGoogle scholar articles

Citation

Stock S, Strzalkowski T, Gottschlich A, et al
P12.02 Adaptor P329G-directed CAR T cells for modular targeting of AML
Journal for ImmunoTherapy of Cancer 2024;12:doi: 10.1136/jitc-2024-ITOC10.56
Online issue publication 
March 20, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.